Literature DB >> 22438019

Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis.

Kristen Sgambat1, Lowell Frank, Ahmad Ellini, Craig Sable, Asha Moudgil.   

Abstract

BACKGROUND: Carnitine plays a key role in energy production in the myocardium. Carnitine deficiency commonly occurs in patients on chronic hemodialysis (HD) and may contribute to cardiomyopathy.
METHODS: Carnitine levels and cardiac function of nine children on HD were assessed before and after 6 months of intravenous levocarnitine supplementation. Standard echocardiographic (ECHO) measures of left ventricular (LV) function as well as strain and strain rate analysis using novel speckle-tracking echocardiography were performed and the results compared to those of a control group of children on chronic HD.
RESULTS: Following carnitine supplementation, total (49.0 ± 1.67 vs. 298.0 ± 31.8 μmol/L) and free carnitine (29.0 ± 1.20 vs. 180.4 ± 19.2 μmol/L) increased (p < 0.0001), and the acyl:free (A:F) carnitine ratio improved (0.73 ± 0.04 vs. 0.65 ± 0.05; p = 0.02). There were no changes in standard ECHO measures of LV function, including end diastolic dimension, mass index, ejection fraction, and fractional shortening. There was significant (p = 0.017) improvement in the longitudinal strain rate (-1.48 ± 0.11 vs -1.91 ± 0.12) after carnitine supplementation in the study group. No improvements in LV function, strain, or strain rate occurred in controls.
CONCLUSIONS: Levocarnitine supplementation improved carnitine levels, the A:F ratio, and longitudinal strain rate in children on HD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22438019     DOI: 10.1007/s00467-012-2144-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.

Authors:  T A Golper; M Wolfson; S Ahmad; R Hirschberg; P Kurtin; L A Katz; R Nicora; D Ashbrook; J D Kopple
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  Can strain rate imaging predict recovery of contraction after acute myocardial infarction?

Authors:  Minna M Kylmälä; Margareta Antila; Sari M Kivistö; Kirsi Lauerma; Lauri Toivonen; Mika K Laine
Journal:  Eur J Echocardiogr       Date:  2011-03-15

3.  Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients.

Authors:  Y Matsumoto; M Sato; H Ohashi; H Araki; M Tadokoro; Y Osumi; H Ito; H Morita; I Amano
Journal:  Am J Nephrol       Date:  2000 May-Jun       Impact factor: 3.754

4.  Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography.

Authors:  Sonali Basu; Lowell H Frank; Kimberly E Fenton; Craig A Sable; Richard J Levy; John T Berger
Journal:  Pediatr Crit Care Med       Date:  2012-05       Impact factor: 3.624

5.  New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography.

Authors:  Thomas Helle-Valle; Jonas Crosby; Thor Edvardsen; Erik Lyseggen; Brage H Amundsen; Hans-Jørgen Smith; Boaz D Rosen; João A C Lima; Hans Torp; Halfdan Ihlen; Otto A Smiseth
Journal:  Circulation       Date:  2005-11-15       Impact factor: 29.690

6.  Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia.

Authors:  B de los Reyes; J A Navarro; R Pérez-García; A Liras; Y Campos; B Bornstein; J Arenas
Journal:  Am J Clin Nutr       Date:  1998-03       Impact factor: 7.045

Review 7.  Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes.

Authors:  I B Fritz; E Arrigoni-Martelli
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

8.  Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: an observational study.

Authors:  G F Romagnoli; A Naso; G Carraro; V Lidestri
Journal:  Curr Med Res Opin       Date:  2002       Impact factor: 2.580

Review 9.  Cardiovascular disease in children with CKD or ESRD.

Authors:  Marc R Lilien; Jaap W Groothoff
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

10.  L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis.

Authors:  Tai Sakurabayashi; Shigeru Miyazaki; Yasuko Yuasa; Shinji Sakai; Masashi Suzuki; Sachio Takahashi; Yoshihei Hirasawa
Journal:  Circ J       Date:  2008-06       Impact factor: 2.993

View more
  5 in total

1.  Oxidative stress and cardiac dysfunction in children with chronic renal failure on regular hemodialysis.

Authors:  Mohammed Al-Biltagi; Osama A Tolba; Maher Ahmed Abd ElHafez; Ahmed Abd ElBasset Abo-Elezz; Eman Kamel El Kady; Sahar Mohey El-Din Hazza
Journal:  Pediatr Nephrol       Date:  2016-03-18       Impact factor: 3.714

Review 2.  Nutrients and micronutrients at risk during renal replacement therapy: a scoping review.

Authors:  Mette M Berger; Marcus Broman; Lui Forni; Marlies Ostermann; Elisabeth De Waele; Paul E Wischmeyer
Journal:  Curr Opin Crit Care       Date:  2021-08-01       Impact factor: 3.359

3.  Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.

Authors:  Kei Fukami; Sho-Ichi Yamagishi; Kazuko Sakai; Makoto Nasu; Seiya Okuda
Journal:  Clin Kidney J       Date:  2014-07-29

Review 4.  Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Int J Mol Sci       Date:  2014-11-05       Impact factor: 5.923

Review 5.  The role of carnitine in maintenance dialysis therapy.

Authors:  Heather A Morgans; Vimal Chadha; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.